Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients

[1]  F. Saad,et al.  Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer. , 2019 .

[2]  Yi-jun Shen,et al.  Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis , 2019, International Urology and Nephrology.

[3]  I. Mills,et al.  Drivers of AR indifferent anti-androgen resistance in prostate cancer cells , 2019, Scientific Reports.

[4]  Qiang Wu,et al.  Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer , 2019, Theranostics.

[5]  Jiameng Liu,et al.  High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[6]  S. Tekin,et al.  TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer , 2019, Journal of Cancer Research and Clinical Oncology.

[7]  G. Naik,et al.  Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC. , 2019, Cancer research.

[8]  Yifeng Jing,et al.  Endothelial cells promote metastasis of prostate cancer by enhancing autophagy , 2018, Journal of experimental & clinical cancer research : CR.

[9]  Wei Tang,et al.  NPRL2 enhances autophagy and the resistance to Everolimus in castration‐resistant prostate cancer , 2018, The Prostate.

[10]  Zhou Shen,et al.  Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress. , 2018, Biochemical and biophysical research communications.

[11]  S. Lipsitz,et al.  Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer , 2018, Prostate Cancer and Prostatic Diseases.

[12]  A. Mulkidjanian,et al.  Induction of autophagy by depolarization of mitochondria , 2018, Autophagy.

[13]  P. Boström,et al.  The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland , 2018, International journal of cancer.

[14]  Hua Han,et al.  GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling , 2018, The Prostate.

[15]  J. Debnath,et al.  Inflammatory signaling cascades and autophagy in cancer , 2018, Autophagy.

[16]  Shuanke Wang,et al.  Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway , 2018, Oncology research.

[17]  R. Bast,et al.  Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression , 2017, Autophagy.

[18]  A. Jemal,et al.  Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening. , 2016, JAMA oncology.

[19]  N. Biglia,et al.  Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer. , 2016, Gynecologic oncology.

[20]  F. Goñi,et al.  Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization , 2016, Autophagy.

[21]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[22]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[23]  Sarah H. Johnson,et al.  Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer , 2016, Modern Pathology.

[24]  Li Haifeng,et al.  Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[25]  Chia-Cheng Yu,et al.  Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer , 2015, Scientific Reports.

[26]  Sheng-Tang Wu,et al.  The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation , 2013, PloS one.

[27]  T. Yamasaki,et al.  Regulation of androgen receptor transactivity and mTOR–S6 kinase pathway by Rheb in prostate cancer cell proliferation , 2010, The Prostate.

[28]  K. W. Kim,et al.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. , 2006, Cancer research.

[29]  D. Mu,et al.  Aurora-A regulates autophagy through the Akt pathway in human prostate cancer. , 2017, Cancer biomarkers : section A of Disease markers.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..